Cell Design Labs

Senti Biosciences

This clinical-stage biotechnology company develops programmable cell and gene therapies using synthetic biology and gene circuits to treat patients with cancer and incurable diseases.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Advancing synthetic immunology

Senti Biosciences develops programmable cell and gene therapies for patients with cancer and other incurable diseases using synthetic gene circuits.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

Juno Therapeutics

This biopharmaceutical company develops immunotherapies using genetically engineered cells to treat patients with various types of cancer.

Humane Genomics

This company develops synthetic oncolytic viral therapies to treat cancer patients by engineering viruses that selectively infect and destroy malignant cells.

ArsenalBio

The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.